The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Effects of Non-invasive Vagus Nerve Stimulation on Inflammatory Markers in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amira Mohamed Taha • Amr Elrosasy • Ahmed S. Mohamed •et.al. DOI: 10.7759/cureus.70613  Abstract The international healthcare community has encountered several difficulties because of the COVID-19 pandemic brought on by SARS-CoV-2. COVID-19 can lead to an […]

Inflammatory and Coagulation Marker Changes -Treated COVID-19 Patients

Akinari Tsukada • Daisuke Katagiri • Shinyu Izumi et. al., DOI: 10.7759/cureus.78836  Abstract Introduction Direct hemoperfusion using polymyxin B-immobilized polystyrene fiber column (PMX-DHP) removes endotoxin and inflammatory mediators from the blood. This study aimed to evaluate […]

A Pilot Case-Control Study of Muscle and Bone Health Status in Patients Who Have Recovered From COVID-19 Infection

Shital Bhor • Dipali Ladkat • Nikhil Shah • Ketan Gondhalekar • Piyush Chaudhari • Anuradha Khadilkar, DOI: 10.7759/cureus.76283  Abstract Background: Coronavirus disease 2019 (COVID-19), resulting from the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects various bodily systems, including […]

COVID-19 Vaccines ‘May Trigger’ Rheumatic Inflammatory Diseases: Study

OCT 15, 2023 – Authored by Marina Zhang via The Epoch Times  A new review suggests that COVID vaccines “may trigger” rheumatic immune-mediated inflammatory diseases, including arthritis, vasculitis, lupus, and adult-onset […]

COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC)

Authors: Laura E Lamb 1, Nivedita Dhar 2, Ryan Timar 3, Melissa Wills 3, Sorabh Dhar 4, Michael B Chancellor 5 PMID: 33213997 PMCID: PMC7644255 DOI: 10.1016/j.mehy.2020.110375 Abstract Coronavirus disease 2019 (COVID-19) causes a wide range of symptoms, including several unexpected symptoms such as […]

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Authors: Chansavath Phetsouphanh, David R. Darley, Daniel B. Wilson, Annett Howe, C. Mee Ling Munier, Sheila K. Patel, Jennifer A. Juno, Louise M. Burrell, Stephen J. Kent, Gregory J. Dore, Anthony D. Kelleher & Gail V. Matthews  Nature Immunology volume 23, pages210–216 (2022) June 30, […]